Condensed Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating expenses:
Research and development	$ 10,645	$ 6,608
Selling, General and Administrative	11,375	3,654
Total operating expenses	22,020	10,262
Loss from operations	(22,020)	(10,262)
Other income (expense):
Interest income	156	131
Interest expense	(142)	(188)
Change in fair value of convertible promissory notes	0	(11,400)
Change in fair value of warrant liability	0	(2,202)
Net loss	$ (22,006)	$ (23,921)
Basic and diluted net loss per share	$ (0.31)	$ (2.05)
Weighted-average shares used in computing net loss per share, basic and diluted	71,011,041	11,652,998